ID Screen® SARS-CoV-2-N IgG Indirect ELISA

Reliable:

• Approved by French authorities further to its evaluation by the French National Reference Centre
• High sensitivity and specificity (99.9%) ensures accurate results, with clear discrimination of positive and negative samples
• Excellent specificity and high positive predictive value, even in low prevalence areas, means a positive result reliably indicates if a person has been exposed to the virus and if the patient has developed antibodies

Rapid and easy-to-use:

• Use manually or with any open automated immunoassay platform
• Ready-to-use reagents
• Results in 95 minutes
• Possibility to operate on inactivated serum/plasma samples to guarantee operator’s safety